[1]于鹏程, 袁莉, 胡灿, 吴越, 徐志远, 程向东.CLDN18 在消化系统肿瘤中表达的意义及现状研究进展 [J]. 肿瘤学杂志,2021,27(10):798-804.
[2]王俏丽.CLAUDIN 18.2 在消化系统恶性肿瘤中作用的研究进展 [J]. 中国肿瘤生物治疗杂志,2022,29(7):681-685.
[3]Gowrikumar S, Singh AB, Dhawan P. Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy. Int J Mol Sci. 2019 Dec 20;21(1):53.
[4]Cao W, Xing H, Li Y, Tian W, Song Y, Jiang Z, Yu J. Claudin 18.2 is a novel molecular biomarker for tumor-targeted immunotherapy. Biomark Res. 2022 May 31;10(1):38.
[5]李澔, 叶显辉, 周俊杰, 等. 胃癌靶向治疗的曙光 ——Claudin18.2[J]. 肿瘤防治研究,2023,50(10):1022-1028.
[6]Hong JY, An JY, Lee J, et al. Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer. Transl Cancer Res. 2020;9(5):3367-3374. doi:10.21037/tcr-19-1876
[7]Sahin U, Koslowski M, Dhaene K, et al. Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin Cancer Res. 2008;14(23):7624-7634. doi:10.1158/1078-0432.CCR-08-1547
[8]范密, 罗婷, 张羽, 杜小波.Claudin 18.2 在恶性实体肿瘤中的研究现状与展望 [J]. 华西医学,2023,38(09):1428-1434.